CymaBay Therapeutics, Inc. Recorded Big Gain
Thu, Jul 23, 2020 at 05:30 PM
CymaBay Therapeutics, Inc. (CBAY:NASDAQ) rocketted at $4.39, representing a gain of 25.1%. The stock appeared on our News Catalysts scanner on Thu 23 Jul 20 at 08:29 AM in the 'BIOTECH' category. From Wed 08 Jul 20, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Tue 12 May 20 at $4.95 with a volume of 88M+, and its share price has been moving sideways in recent weeks.
About CymaBay Therapeutics, Inc. (CBAY:NASDAQ)
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.
Top 10 Gainers:
- Milestone Pharmaceuticals Inc. (MIST:NASDAQ), 166.77%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 119.86%
- RigNet, Inc. (RNET:NASDAQ), 48.34%
- Brightcove Inc. (BCOV:NASDAQ), 44.24%
- PolyMet Mining Corp. (PLM:NYSEMKT), 35.93%
- Mogo Inc. (MOGO:NASDAQ), 35%
- Lightbridge Corporation (LTBR:NASDAQ), 29.87%
- Helix Energy Solutions Group, Inc. (HLX:NYSE), 26.96%
- Reed's, Inc. (REED:NASDAQ), 25.96%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 25.07%